title: Effects of prodynorphin deletion on striatal dopamine in mice during normal aging and in response to MPTP.
abstract: Dynorphins, endogenous neuropeptides found in striatonigral neurons, have been observed to exhibit dopamine-inhibitory actions and under some circumstances possess intrinsic neurotoxic activity. To test the hypothesis that dynorphin suppression mitigates effects of aging on the striatal dopaminergic system, HPLC quantitation of dopamine and related amines was performed on striatal homogenates of wild-type (WT) mice and mice lacking the prodynorphin (Pdyn) gene at varying ages. Pdyn knockout (KO) mice at 10 and 20 months show significant elevations in striatal dopamine compared to 3-month mice. Differences in tyrosine hydroxylase (TH) immunoreactivity could not account for these findings, but phosphorylation of TH at Ser40, but not Ser31, was enhanced in aged Pdyn KO mice. Systemic administration of MPTP produced significant dopamine depletion in an age-dependent manner, but Pdyn deletion conferred no protection against MPTP-induced dopamine loss, arguing against a mechanism by which Pdyn deletion enhances dopaminergic neuron survival. The above findings demonstrate an age-dependent inhibitory effect of dynorphins on striatal dopamine synthesis via modulation of TH activity.
authors.affiliation: Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA.
authors.forename: Xuan V
authors.initials: XV
authors.lastname: Nguyen
authors.forename: Mei
authors.initials: M
authors.lastname: Liu
authors.forename: Hyoung-Chun
authors.initials: HC
authors.lastname: Kim
authors.forename: Guoying
authors.initials: G
authors.lastname: Bing
mesh_terms: D000375:Aging / Q000378:metabolism*; D000595:Amino Acid Sequence / Q000502:physiology; D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism* / Q000503:physiopathology; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism*; D004745:Enkephalins / Q000235:genetics*; D005260:Female; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009434:Neural Pathways / Q000378:metabolism / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000378:metabolism* / Q000503:physiopathology; D010766:Phosphorylation / Q000187:drug effects; D011498:Protein Precursors / Q000235:genetics*; D012694:Serine / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism / Q000503:physiopathology; D014446:Tyrosine 3-Monooxygenase / Q000737:chemistry / Q000378:metabolism; D015854:Up-Regulation / Q000235:genetics
chemical_list: D004745:Enkephalins; D011498:Protein Precursors; D012694:Serine; C033660:preproenkephalin; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine